Oragen Therapeutics

🗓 Founded 2025👥 5 employees💰 Last funded Jun 2026
Biotechnology Research
LinkedIn
We are a preclinical-stage biotech company focused on developing revolutionary therapies to address Inflammatory Bowel Diseases. Harnessing the unique capabilities of our Genetic Medicines Oral Delivery platform we aim to overcome major limitations of current treatments and unlock the groundbreaking potential of Genetic Medicines in IBDs, driving transformative change in a field with critical medical needs.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2025
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Oragen Therapeutics?
Oragen Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Oragen Therapeutics last raise funding?
The most recent investment in Oragen Therapeutics recorded on gritt.io was in June 2026.
When was Oragen Therapeutics founded?
Oragen Therapeutics was founded in 2025.
What industry is Oragen Therapeutics in?
Oragen Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.